1Yabushita H, Bouma BE, Houser SL,et al. Characterization of human ath-erosclerosis by optical coherence tomography [J]. Circulation, 2002 ; 106 (13) :1640-5.
2Li QX,Fu QQ,Shi SW,et aL Relationship between plasma inflammatory markers and plaque ~larnus cap thickness determined by intravascular op- tical coherence tomography[J]. Heart ,2010 ;96 ( 3 ) : 196-201.
3Lemaltre V, Kim HE, Fomey-Prescott M, et al. Transgenic expression of matrix metalloproteinase-9 modulates collagen deposition in a mouse mod- el of atherosclerosis[J]. Atherosclerosis ,2009 ;205 ( 1 ) :107-12.
5Manginas A, Bei E, Chaidaroglou A, et al. Peripheral levels of matrix met- alloproteinase-9 ,interleukin-6 and C-reactive protein are elevated in pa- tients with acute coronary syndromes : correlations with serum troponin I [J].Clin Cardio1,2005 ;28 (4) : 182-6.
6Funayama H, Ishikawa SE, Kubo N, et al. Increases in interlenkin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction[J]. Cire J ,2004 ;68 (5) :451 -4.
7Burke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly[J]. N Engl J Med, 1997 ;336 (18) : 1276-82.
